title: Nephrolithiasis with dorzolamide.
authors.affiliation: Department of Ophthalmology, John A. Moran Eye Center, Salt Lake City, Utah 84132, USA.
authors.forename: J
authors.initials: J
authors.lastname: Carlsen
authors.forename: J
authors.initials: J
authors.lastname: Durcan
authors.forename: N
authors.initials: N
authors.lastname: Zabriskie
authors.forename: M
authors.initials: M
authors.lastname: Swartz
authors.forename: A
authors.initials: A
authors.lastname: Crandall
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects*; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007669:Kidney Calculi / Q000139:chemically induced*; D008297:Male; D013449:Sulfonamides / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide